Michael D. Pak

Array ( [id] => 7432640 [patent_doc_number] => 20040209839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Human peroxisome proliferator activated receptor gamma' [patent_app_type] => new [patent_app_number] => 10/847732 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18335 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209839.pdf [firstpage_image] =>[orig_patent_app_number] => 10847732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4516284 [patent_doc_number] => 07932364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Compositions and methods for the preparation of human growth hormone glycosylation mutants' [patent_app_type] => utility [patent_app_number] => 10/556094 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 36422 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932364.pdf [firstpage_image] =>[orig_patent_app_number] => 10556094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903650 [patent_doc_number] => 07335735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Intracellular estradiol binding protein' [patent_app_type] => utility [patent_app_number] => 10/840038 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11880 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335735.pdf [firstpage_image] =>[orig_patent_app_number] => 10840038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466332 [patent_doc_number] => 20040198705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Modulation of steroid hormone uptake' [patent_app_type] => new [patent_app_number] => 10/479875 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28282 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198705.pdf [firstpage_image] =>[orig_patent_app_number] => 10479875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074336 [patent_doc_number] => 20050147604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Means and methods for diagnosing and treating affective disorders' [patent_app_type] => utility [patent_app_number] => 10/825593 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 53377 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10825593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747454 [patent_doc_number] => 20060110385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Means and methods for diagnosing and treating affective disorders' [patent_app_type] => utility [patent_app_number] => 10/553298 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 53397 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110385.pdf [firstpage_image] =>[orig_patent_app_number] => 10553298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668511 [patent_doc_number] => 07094752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Peptide ligands of the urokinase receptor' [patent_app_type] => utility [patent_app_number] => 10/821544 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19476 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094752.pdf [firstpage_image] =>[orig_patent_app_number] => 10821544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131218 [patent_doc_number] => 07700304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Methods of screening disorders related to apoE' [patent_app_type] => utility [patent_app_number] => 10/820618 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 23602 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700304.pdf [firstpage_image] =>[orig_patent_app_number] => 10820618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341309 [patent_doc_number] => 20040191215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Compositions for induction of a therapeutic response' [patent_app_type] => new [patent_app_number] => 10/808927 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23548 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191215.pdf [firstpage_image] =>[orig_patent_app_number] => 10808927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190078 [patent_doc_number] => 20040204351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Soluble proteins that inhibit cytokine signal transduction pathways' [patent_app_type] => new [patent_app_number] => 10/490593 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19001 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204351.pdf [firstpage_image] =>[orig_patent_app_number] => 10490593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409688 [patent_doc_number] => 20040176296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 10/806018 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 85150 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176296.pdf [firstpage_image] =>[orig_patent_app_number] => 10806018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233931 [patent_doc_number] => 20040157259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Novel human ion channel protein and polynucleotides encoding the same' [patent_app_type] => new [patent_app_number] => 10/803268 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8572 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157259.pdf [firstpage_image] =>[orig_patent_app_number] => 10803268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7441816 [patent_doc_number] => 20040185548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Hybrid receptors for efficient assay of modulators of receptor protein-tyrosine kinases' [patent_app_type] => new [patent_app_number] => 10/801868 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14299 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185548.pdf [firstpage_image] =>[orig_patent_app_number] => 10801868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7676951 [patent_doc_number] => 20040152875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Novel purinergic receptor' [patent_app_type] => new [patent_app_number] => 10/706532 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10722 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152875.pdf [firstpage_image] =>[orig_patent_app_number] => 10706532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056851 [patent_doc_number] => 20070059773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Identification of therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/547462 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9292 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059773.pdf [firstpage_image] =>[orig_patent_app_number] => 10547462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922207 [patent_doc_number] => 20060240436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar)' [patent_app_type] => utility [patent_app_number] => 10/548962 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32976 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240436.pdf [firstpage_image] =>[orig_patent_app_number] => 10548962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308885 [patent_doc_number] => 20040142426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Novel proteins and methods for producing the proteins' [patent_app_type] => new [patent_app_number] => 10/785109 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21180 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142426.pdf [firstpage_image] =>[orig_patent_app_number] => 10785109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286878 [patent_doc_number] => 20040146926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Chemokine receptor' [patent_app_type] => new [patent_app_number] => 10/787018 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23934 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146926.pdf [firstpage_image] =>[orig_patent_app_number] => 10787018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334559 [patent_doc_number] => 20040132038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Nuclear hormone receptor ligand binding domain' [patent_app_type] => new [patent_app_number] => 10/469858 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19321 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132038.pdf [firstpage_image] =>[orig_patent_app_number] => 10469858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149546 [patent_doc_number] => 20040171018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Mouse farnesoid x receptor sequences for use in comparative pharmacology' [patent_app_type] => new [patent_app_number] => 10/483637 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8496 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171018.pdf [firstpage_image] =>[orig_patent_app_number] => 10483637 [rel_patent_id] =>[rel_patent_doc_number] =>)